[1]. Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.
Anticancer research [Volume]44 [Issue]2 [Page]781 -786 (2024/) [Reviewed] Yes
[DOI] [2]. Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
International journal of urology : official journal of the Japanese Urological Association [Volume]30 [Issue]9 [Page]730 -736 (2023/) [Reviewed] Yes
[DOI] [3]. Therapeutic effects of KCC2 chloride transporter activation on detrusor overactivity in mice with spinal cord injury.
American journal of physiology. Renal physiology [Volume]324 [Issue]4 [Page]F353 -F361 (2023/) [Reviewed] Yes
[DOI] [4]. Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot-assisted radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association [Volume]30 [Issue]1 [Page]57 -61 (2023/) [Reviewed] Yes
[DOI] [5]. Effects of Changes in Erectile Function After Holmium Laser Enucleation of the Prostate on Postoperative Outcomes in Patients With Benign Prostatic Hyperplasia.
In vivo (Athens, Greece) [Volume]36 [Issue]6 [Page]2960 -2964 (2022/) [Reviewed] Yes
[DOI]